For a cell technology that has spent much of the past three decades on the verge of a breakthrough, heterojunction (HJT) is enjoying another moment in the spotlight. This time, however, the setting is somewhat unexpected – rather than the established manufacturing centers of China and Southeast Asia, some of the most significant new commitments to HJT are emerging in the United States, Finlay Colville reports.